Sodium-glucose co-transporter 2 inhibitor treatment and risk of atrial fibrillation: Scandinavian cohort studyArvid Engström, Peter Ueda(Karolinska Institutet)UnknownDecember 12, 202210.2337/figshare.21562863Cited by 0SaveCiteExport RISWatch citationsRelated PapersThe comparative cardiovascular and renal effectiveness of sodium‐glucose co‐transporter‐2 inhibitors and glucagon‐like peptide‐1 receptor agonists: A Scandinavian cohort study|Diabetes Obesity and Metabolism|2021|31